^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
MHB088C
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Minghui Pharma
Drug class:
Topoisomerase I inhibitor, B7-H3-targeted antibody-drug conjugate
Related drugs:
Phase 1/2
Minghui Pharmaceutical Pty Ltd
Not yet recruiting
Last update posted :
01/09/2023
Initiation :
01/23/2023
Primary completion :
01/31/2026
Completion :
07/31/2026
MSI
|
MSI-H/dMMR
|
MHB088C
Share
